Arcellx Inc Sustainability Reports
Arcellx, Inc. is a clinical-stage biotechnology company focused on developing innovative cell therapies and immunotherapies for patients with cancer and other incurable diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00QHJM4W4
3 reports from 2021 to 2023
Company Profile
Arcellx, Inc. is a clinical-stage biotechnology company focused on developing innovative cell therapies and immunotherapies for patients with cancer and other incurable diseases.
Reports
3 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
